
Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:19

Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
2023-12-01 15:48

Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker
2023-11-13 19:56

Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:48

Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:22

Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:23

Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:47

European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:48

Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:48

When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:56

Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
2023-10-05 14:52

U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
By Maggie Fick LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory
2023-09-21 16:51